Samuel Hellman to Disease Progression
This is a "connection" page, showing publications Samuel Hellman has written about Disease Progression.
Connection Strength
0.200
-
The clinical significance of tumor progression: breast cancer as a model. Cancer J. 2000 Apr; 6 Suppl 2:S131-3.
Score: 0.033
-
Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol. 2000 Feb; 18(3):591-9.
Score: 0.033
-
Aging, progression, and phenotype in breast cancer. J Clin Oncol. 1998 Aug; 16(8):2686-92.
Score: 0.030
-
Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am. 1997 Jul-Aug; 3(4):224-9.
Score: 0.027
-
Darwin's clinical relevance. Cancer. 1997 Jun 15; 79(12):2275-81.
Score: 0.027
-
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One. 2012; 7(12):e50141.
Score: 0.020
-
MicroRNA expression characterizes oligometastasis(es). PLoS One. 2011; 6(12):e28650.
Score: 0.019
-
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004 Dec; 25(6):1677-83.
Score: 0.011